Overview | Medtronic
Medtronic Investors

Creating
Long-term
Shareholder
Value

Our leading technologies and services create value on a global scale.

Learn More

Latest Investor Information

May 23, 2019
Q4 2019 Medtronic plc Earnings Conference Call
March 17, 2019
Investor & Analyst Briefing from ACC in New Orleans
March 12, 2019
Barclays Global Healthcare Conference 2019

Latest Press Releases

May 22, 2019Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients
May 16, 2019Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases
May 11, 2019Medtronic Reveals Results of First-In-Human Study for Investigational Extravascular ICD System
May 10, 2019New Studies Highlight Underuse of Implantable Cardiac Devices
Read More
 

Medtronic ESG & Corporate Citizenship Highlights

Medtronic Marks a Decade on the North American Dow Jones Sustainability Index (DJSI)

LEARN MORE

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

LEARN MORE

QUARTERLY

RESULTS

Medtronic Q2 revenue results and financial tables.

LEARN MORE

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

LEARN MORE
 

INSTITUTIONAL
INVESTOR AND
ANALYST MEETING

2018

Promising therapy and product innovation detailed by company leaders
READ HIGHLIGHTS

ACCESS WEBCAST REPLAY

img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

READ MORE
  
 
img.alt

Medtronic Spotlight

Medtronic CEO, Omar Ishrak sits down with CNBC’s Jim Cramer, to talk about the company’s analyst day and it’s fastest growing products.

Play Video
 
img.alt

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

EQ Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations

View All
X